InsiderTrades.com logo
Tim Sykes’ Urgent Trade Alert: “Make this move now”
From Timothy Sykes   |   Ad
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
Click here to see a unique election-year trade

ZURA Insider Trading

Insider Ownership Percentage: 15.80%
Insider Buying (Last 12 Months): $1,030,998.38
Insider Selling (Last 12 Months): $200,187.36

Zura Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Zura Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zura Bio Share Price & Price History

Current Price: $4.44
Price Change: ▲ Price Increase of +0.14 (3.26%)
As of 09/20/2024 01:00 AM ET

This chart shows the closing price history over time for ZURA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tim Sykes’ Urgent Trade Alert: “Make this move now”
From Timothy Sykes   |   Ad
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
Click here to see a unique election-year trade

Zura Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/4/2024Someit SidhuDirectorSell51,728$3.87$200,187.362,085,418View SEC Filing Icon  
5/17/2024Van Amstel Arnout PloosDirectorBuy80,000$6.20$496,000.00100,000View SEC Filing Icon  
4/22/2024Amit MunshiDirectorBuy159,744$3.13$499,998.72777,384View SEC Filing Icon  
4/22/2024Kiran NistalaEVPBuy3,195$3.13$10,000.353,195View SEC Filing Icon  
4/22/2024Michael HowellInsiderBuy7,987$3.13$24,999.317,987View SEC Filing Icon  
6/5/2023Amit MunshiDirectorBuy117,647$4.25$499,999.75617,640View SEC Filing Icon  
See Full Table
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for Zura Bio (NASDAQ:ZURA)

61.14% of Zura Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZURA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Zura Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/19/2024Point72 Asset Management L.P.2,413,127$8.45M0.0%N/A5.535%Search for SEC Filing on Google Icon
8/16/2024Forefront Analytics LLC41,569$0.15M0.1%+22.1%0.095%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC12,319$43K0.0%N/A0.028%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC2,524,000$8.83M0.1%+53.2%5.790%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC223,335$0.78M0.1%-50.4%0.512%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC4,642,241$16.25M3.1%+68.3%10.649%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC17,400$61K0.0%+51.3%0.040%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp47,109$0.17M0.0%+15.8%0.074%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC450,009$1.16M0.1%N/A1.044%Search for SEC Filing on Google Icon
2/15/2024Forefront Analytics LLC21,229$99K0.0%+46.8%0.049%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC1,824,000$8.52M0.1%+15.4%4.233%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC1,580,000$10.43M0.2%+66.3%3.667%Search for SEC Filing on Google Icon
11/14/2023Lynx1 Capital Management LP9,917$65K0.0%N/A0.023%Search for SEC Filing on Google Icon
11/13/2023Eisler Capital US LLC100,000$0.66M0.0%N/A0.232%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC404,040$2.67M0.8%+152.5%0.938%Search for SEC Filing on Google Icon
11/8/2023Forefront Analytics LLC14,464$95K0.1%N/A0.034%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp33,973$0.22M0.0%N/A0.079%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates77,356$0.51M0.0%+14.0%0.180%Search for SEC Filing on Google Icon
8/15/2023Silverarc Capital Management LLC160,000$1.31M0.4%N/A0.591%Search for SEC Filing on Google Icon
8/15/2023Suvretta Capital Management LLC2,850,000$23.37M1.2%N/A10.536%Search for SEC Filing on Google Icon
8/14/2023Great Point Partners LLC3,295,000$27.02M5.3%N/A12.181%Search for SEC Filing on Google Icon
8/14/2023Deep Track Capital LP2,523,000$20.69M1.0%N/A5.855%Search for SEC Filing on Google Icon
8/10/2023Monashee Investment Management LLC240,000$1.97M0.5%N/A0.887%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.3,649$30K0.0%N/A0.013%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates67,875$0.56M0.0%N/A0.251%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Zura Bio logo
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.
Read More on Zura Bio

Today's Range

Now: $4.44
Low: $4.22
High: $4.55

50 Day Range

MA: $3.73
Low: $3.25
High: $4.44

52 Week Range

Now: $4.44
Low: $2.00
High: $7.22

Volume

4,563,213 shs

Average Volume

321,645 shs

Market Capitalization

$193.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.16

Who are the company insiders with the largest holdings of Zura Bio?

Zura Bio's top insider shareholders include:
  1. Someit Sidhu (Director)
  2. Amit Munshi (Director)
  3. Van Amstel Arnout Ploos (Director)
  4. Michael Howell (Insider)
  5. Kiran Nistala (EVP)
Learn More about top insider investors at Zura Bio.

Who are the major institutional investors of Zura Bio?

Zura Bio's top institutional investors include:
  1. Great Point Partners LLC — 10.65%
  2. Armistice Capital LLC — 5.79%
  3. Point72 Asset Management L.P. — 5.54%
  4. Affinity Asset Advisors LLC — 0.51%
  5. Bank of New York Mellon Corp — 0.07%
  6. Forefront Analytics LLC — 0.10%
Learn More about top institutional investors of Zura Bio stock.

Which institutional investors are selling Zura Bio stock?

During the last quarter, ZURA stock was sold by these institutional investors:
  1. Affinity Asset Advisors LLC

Which institutional investors are buying Zura Bio stock?

Within the previous quarter, ZURA stock was purchased by institutional investors including:
  1. Point72 Asset Management L.P.
  2. Great Point Partners LLC
  3. Armistice Capital LLC
  4. AQR Capital Management LLC
  5. Forefront Analytics LLC
  6. Bank of New York Mellon Corp
  7. Renaissance Technologies LLC
In the last year, these company insiders have bought Zura Bio stock:
  1. Someit Sidhu (Director)
  2. Amit Munshi (Director)
  3. Van Amstel Arnout Ploos (Director)
  4. Michael Howell (Insider)
Learn More investors buying Zura Bio stock.
Tim Sykes’ Urgent Trade Alert: “Make this move now”
From Timothy Sykes   |   Ad
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
Click here to see a unique election-year trade